Feed Preview

Parkinson's Disease

Parkinson's Disease diagram by Studio BKK, Shutterstock
Studio BKK, Shutterstock

Parkinson's Disease is a progressive neurodegenerative disorder characterized by loss of muscle control, including trembling of the limbs and impaired balance. Here is the latest research.

Top 20 most recent papers
May 23, 2020

Dopaminergic function in spinocerebellar ataxia type 6 patients with and without parkinsonism

Journal of Neurology
Yoshihiko HorimotoHidehiro Kabasawa
May 24, 2020
Review

Deep Phenotyping of Parkinson's Disease

Journal of Parkinson's Disease
E Ray DorseyMichael P McDermott
May 23, 2020

Astrocyte glutamate transporters are increased in an early sporadic model of synucleinopathy

Neurochemistry International
Luan Pereira DinizFlávia Carvalho Alcantara Gomes
May 24, 2020
Review

The effectiveness of acupuncture for Parkinson's disease: An overview of systematic reviews

Complementary Therapies in Medicine
Liujiao CaoKehu Yang
May 24, 2020

Aripiprazole-induced Parkinsonism with pregabalin as a confounder

Acta neurologica Belgica
Upinder KaurSankha Shubhra Chakrabarti
May 23, 2020

Dietary antioxidants associated with slower progression of parkinsonian signs in older adults

Nutritional Neuroscience
Puja AgarwalMartha C Morris
May 23, 2020

The effect of chronic neuropeptide-S treatment on non-motor parameters in experimental model of Parkinson's disease

The International Journal of Neuroscience
Osman SinenAysel Agar
May 25, 2020

Visual hallucinations and illusions in Parkinson's disease: the role of ocular pathology

Journal of Neurology
Ana MarquesFranck Durif
May 24, 2020
Open Access

Recommendations for the Organization of Multidisciplinary Clinical Care Teams in Parkinson's Disease

Journal of Parkinson's Disease
Danique L M RadderBastiaan R Bloem
May 23, 2020
Review

Neuropsychiatric Aspects of Impulse Control Disorders

The Psychiatric Clinics of North America
Bruno SilvaAndrea E Cavanna
May 24, 2020

Increased alpha-synuclein tear fluid levels in patients with Parkinson's disease

Scientific Reports
Fabian MaassPaul Lingor
May 24, 2020

CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive Trajectories

Movement Disorders : Official Journal of the Movement Disorder Society
Stefanie LercheKathrin Brockmann
May 24, 2020
Review

Overview of sleep disturbances and their management in Parkinson plus disorders

Journal of the Neurological Sciences
Amitabh BhattacharyaPramod Kumar Pal
May 24, 2020
Open Access

Early Reactive A1 Astrocytes Induction by the Neurotoxin 3-Nitropropionic Acid in Rat Brain

International Journal of Molecular Sciences
Carmen Lopez-SanchezCarlos Gutierrez-Merino
May 24, 2020
Review

Fractalkine (CX3CL1) signaling and neuroinflammation in Parkinson's disease: Potential clinical and therapeutic implications

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Efthalia AngelopoulouChristina Piperi

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/parkinsons-disease/89d498c3-24c9-4242-a3bd-d3af3b2a8535